IL25 and breast neoplasm: For a further understanding of the clinical relevance of IL-25, we examined IL-25 expression in all the four major molecular subtypes of human breast tumors, including Luminal A, Luminal B, Triple negative/basal-like, and HER2-enriched types, by immunohistochemical analysis.